Guggenheim Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $6
Portfolio Pulse from Benzinga Newsdesk
Guggenheim has initiated coverage on Sophia Genetics (NASDAQ:SOPH) with a Buy rating and set a price target of $6.
June 27, 2024 | 11:11 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guggenheim has initiated coverage on Sophia Genetics with a Buy rating and set a price target of $6.
The initiation of coverage with a Buy rating and a specific price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100